Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
about
Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn's Disease.Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review.The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives.
P2860
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@ast
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@en
type
label
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@ast
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@en
prefLabel
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@ast
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@en
P2093
P2860
P1476
Reinduction with Certolizumab ...... Data from the PRECiSE 4 Study.
@en
P2093
Alexandra Gutierrez
Cem Kayhan
Charles Randall
David A Schwartz
David Binion
David T Rubin
Ellen Scherl
Gordana Kosutic
Iram Hasan
P2860
P304
P356
10.1097/MIB.0000000000000805
P577
2016-07-04T00:00:00Z